Skip to main content Accessibility help
×
Home

The usefulness of brain natriuretic peptide in simple congenital heart disease – a systematic review

Published online by Cambridge University Press:  20 September 2012


Jannet A. Eindhoven
Affiliation:
Department of Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
Annemien E. van den Bosch
Affiliation:
Department of Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
Eric Boersma
Affiliation:
Department of Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
Jolien W. Roos-Hesselink
Affiliation:
Department of Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
Corresponding
E-mail address:

Abstract

Brain natriuretic peptide and N-terminal pro-brain natriuretic peptide are two well-established markers for cardiac failure in acquired heart disease. Nevertheless, the clinical utility of these markers in patients with congenital heart disease remains unclear. Therefore, the aim of this study was to evaluate the diagnostic and prognostic value of these markers in patients with congenital heart disease. A PubMed and EMBASE literature search was executed with focus on the most common simple congenital heart defects, atrial septal defect and ventricular septal defect. Data on brain natriuretic peptide measurement, cardiac function parameters, and follow-up were collected. In patients with atrial or ventricular septal defect, brain natriuretic peptide levels were mildly increased when compared with healthy age-matched controls. Shunt severity and pulmonary artery pressure correlated strongly with natriuretic peptide levels. A clear association between brain natriuretic peptide and functional class was demonstrated. After closure of the defect, a rise in brain natriuretic peptide levels in the first hours to days was observed. After longer follow-up, natriuretic peptide levels decreased and became comparable to pre-procedural values. In conclusion, this systematic review shows that brain natriuretic peptide levels are mildly increased in patients with unrepaired and repaired atrial or ventricular septal defect. Brain natriuretic peptide measurement might be a useful additional tool in the diagnostic work-up of patients with atrial or ventricular septal defect. Further investigation in a larger, prospective study with long-term follow-up is warranted to elucidate the true prognostic value of natriuretic peptides in patients with simple congenital heart disease.


Type
Review Article
Copyright
Copyright © Cambridge University Press 2012 

Access options

Get access to the full version of this content by using one of the access options below.

References

1. van der Linde, D, Konings, EE, Slager, MA, et al. Birth prevalence of congenital heart disease worldwide: a systematic review and meta-analysis. J Am Coll Cardiol 2011; 58: 22412247.CrossRefGoogle ScholarPubMed
2. Levin, ER, Gardner, DG, Samson, WK. Natriuretic peptides. N Engl J Med 1998; 339: 321328.Google ScholarPubMed
3. Jessup, M, Abraham, WT, Casey, DE, et al. 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 2009; 119: 19772016.Google Scholar
4. Uz, O, Aparci, M, Acar, G, et al. Association of plasma B-type natriuretic peptide levels with shunt size in young adults with atrial septal defect. Echocardiography 2011; 28: 243247.CrossRefGoogle Scholar
5. Jan, SL, Fu, YC, Hwang, B, Lin, SJ. B-type natriuretic peptide in children with atrial or ventricular septal defect: a cardiac catheterization study. Biomarkers 2012; 17: 166171.CrossRefGoogle ScholarPubMed
6. Masutani, S, Taketazu, M, Mihara, C, et al. Usefulness of early diastolic mitral annular velocity to predict plasma levels of brain natriuretic peptide and transient heart failure development after device closure of atrial septal defect. Am J Cardiol 2009; 104: 17321736.CrossRefGoogle ScholarPubMed
7. Attenhofer Jost, CH, Oechslin, E, Seifert, B, et al. Remodelling after surgical repair of atrial septal defects within the oval fossa. Cardiol Young 2002; 12: 506512.CrossRefGoogle Scholar
8. Chamakou, AC, Dede, E, Moutafi, A, et al. Neurohormonal and cytokine fluctuations following transcatheter closure for an atrial septal defect. Cytokine 2012; 57: 130135.CrossRefGoogle ScholarPubMed
9. Eerola, A, Jokinen, E, Pihkala, JI. Serum levels of natriuretic peptides in children with various types of loading conditions. Scand Cardiovasc J 2009; 43: 187193.CrossRefGoogle ScholarPubMed
10. Eerola, A, Pihkala, JI, Boldt, T, Mattila, IP, Poutanen, T, Jokinen, E. Hemodynamic improvement is faster after percutaneous ASD closure than after surgery. Catheter Cardiovasc Interv 2007; 69: 432441; discussion 442.CrossRefGoogle Scholar
11. Kunii, Y, Kamada, M, Ohtsuki, S, et al. Plasma brain natriuretic peptide and the evaluation of volume overload in infants and children with congenital heart disease. Acta Med Okayama 2003; 57: 191197.Google ScholarPubMed
12. Mir, TS, Falkenberg, J, Friedrich, B, et al. Levels of brain natriuretic peptide in children with right ventricular overload due to congenital cardiac disease. Cardiol Young 2005; 15: 396401.CrossRefGoogle ScholarPubMed
13. Muta, H, Ishii, M, Maeno, Y, Akagi, T, Kato, H. Quantitative evaluation of the changes in plasma concentrations of cardiac natriuretic peptide before and after transcatheter closure of atrial septal defect. Acta Paediatr 2002; 91: 649652.CrossRefGoogle ScholarPubMed
14. Nagaya, N, Nishikimi, T, Uematsu, M, et al. Secretion patterns of brain natriuretic peptide and atrial natriuretic peptide in patients with or without pulmonary hypertension complicating atrial septal defect. Am Heart J 1998; 136: 297301.CrossRefGoogle ScholarPubMed
15. Nakagawa, K, Akagi, T, Taniguchi, M, et al. Transcatheter closure of atrial septal defect in a geriatric population. Catheter Cardiovasc Interv 2012; 80: 8490.CrossRefGoogle Scholar
16. Schoen, SP, Zimmermann, T, Kittner, T, et al. NT-proBNP correlates with right heart haemodynamic parameters and volumes in patients with atrial septal defects. Eur J Heart Fail 2007; 9: 660666.CrossRefGoogle ScholarPubMed
17. Takaya, J, Ikemoto, Y, Teraguchi, M, Nogi, S, Kobayashi, Y. Plasma nitric oxide products correlate with cardiac index of congenital heart disease. Pediatr Cardiol 2000; 21: 378381.CrossRefGoogle ScholarPubMed
18. Trojnarska, O, Szyszka, A, Gwizdala, A, et al. Evaluation of exercise capacity with cardiopulmonary exercise testing and type B natriuretic peptide concentrations in adult patients with patent atrial septal defect. Cardiology 2006; 106: 154160.CrossRefGoogle ScholarPubMed
19. Weber, M, Dill, T, Deetjen, A, et al. Left ventricular adaptation after atrial septal defect closure assessed by increased concentrations of N-terminal pro-brain natriuretic peptide and cardiac magnetic resonance imaging in adult patients. Heart 2006; 92: 671675.CrossRefGoogle ScholarPubMed
20. Wu, ET, Akagi, T, Taniguchi, M, et al. Differences in right and left ventricular remodeling after transcatheter closure of atrial septal defect among adults. Catheter Cardiovasc Interv 2007; 69: 866871.CrossRefGoogle ScholarPubMed
21. Chen, LP, Wei, TM, Wang, LX. Relationship between pericardial fluid B-type natriuretic peptide and ventricular structure and function. Arch Med Res 2007; 38: 326329.CrossRefGoogle Scholar
22. Mainwaring, RD, Parise, C, Wright, SB, Juris, AL, Achtel, RA, Fallah, H. Brain natriuretic peptide levels before and after ventricular septal defect repair. Ann Thorac Surg 2007; 84: 20662069.CrossRefGoogle ScholarPubMed
23. Man, BL, Cheung, YF. Plasma brain natriuretic peptide and systemic ventricular function in asymptomatic patients late after the Fontan procedure. Heart Vessels 2007; 22: 398403.CrossRefGoogle Scholar
24. Oyamada, J, Toyono, M, Shimada, S, et al. Noninvasive estimation of left ventricular end-diastolic pressure using tissue Doppler imaging combined with pulsed-wave Doppler echocardiography in patients with ventricular septal defects: a comparison with the plasma levels of the B-type natriuretic peptide. Echocardiography 2008; 25: 270277.CrossRefGoogle Scholar
25. Paul, MA, Backer, CL, Binns, HJ, et al. B-type natriuretic peptide and heart failure in patients with ventricular septal defect: a pilot study. Pediatr Cardiol 2009; 30: 10941097.CrossRefGoogle ScholarPubMed
26. Suda, K, Matsumura, M, Matsumoto, M. Clinical implication of plasma natriuretic peptides in children with ventricular septal defect. Pediatr Int 2003; 45: 249254.CrossRefGoogle ScholarPubMed
27. Toyono, M, Harada, K, Tamura, M, et al. Paradoxical relationship between B-type natriuretic peptide and pulmonary vascular resistance in patients with ventricular septal defect and concomitant severe pulmonary hypertension. Pediatr Cardiol 2008; 29: 6569.CrossRefGoogle ScholarPubMed
28. Westerlind, A, Wahlander, H, Lindstedt, G, Lundberg, PA, Holmgren, D. Clinical signs of heart failure are associated with increased levels of natriuretic peptide types B and A in children with congenital heart defects or cardiomyopathy. Acta Paediatr 2004; 93: 340345.CrossRefGoogle ScholarPubMed
29. Trojnarska, O, Gwizdala, A, Katarzynski, S, et al. The BNP concentrations and exercise capacity assessment with cardiopulmonary stress test in cyanotic adult patients with congenital heart diseases. Int J Cardiol 2010; 139: 241247.CrossRefGoogle Scholar
30. Iversen, K, Jensen, AS, Jensen, TV, Vejlstrup, NG, Sondergaard, L. Combination therapy with bosentan and sildenafil in Eisenmenger syndrome: a randomized, placebo-controlled, double-blinded trial. Eur Heart J 2010; 31: 11241131.CrossRefGoogle ScholarPubMed
31. Williams, R, Houser, L, Miner, P, Aboulhosn, J. Efficacy and safety of bosentan in adults with simple and complex Eisenmenger's syndrome. Congenit Heart Dis 2012; 7: 1215.CrossRefGoogle ScholarPubMed
32. Redfield, MM, Rodeheffer, RJ, Jacobsen, SJ, Mahoney, DW, Bailey, KR, Burnett, JC Jr. Plasma brain natriuretic peptide concentration: impact of age and gender. J Am Coll Cardiol 2002; 40: 976982.CrossRefGoogle Scholar

Altmetric attention score


Full text views

Full text views reflects PDF downloads, PDFs sent to Google Drive, Dropbox and Kindle and HTML full text views.

Total number of HTML views: 7
Total number of PDF views: 71 *
View data table for this chart

* Views captured on Cambridge Core between September 2016 - 2nd December 2020. This data will be updated every 24 hours.

Hostname: page-component-79f79cbf67-xsjvs Total loading time: 7.64 Render date: 2020-12-02T07:21:29.240Z Query parameters: { "hasAccess": "0", "openAccess": "0", "isLogged": "0", "lang": "en" } Feature Flags last update: Wed Dec 02 2020 07:06:18 GMT+0000 (Coordinated Universal Time) Feature Flags: { "metrics": true, "metricsAbstractViews": false, "peerReview": true, "crossMark": true, "comments": true, "relatedCommentaries": true, "subject": true, "clr": false, "languageSwitch": true }

Send article to Kindle

To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

The usefulness of brain natriuretic peptide in simple congenital heart disease – a systematic review
Available formats
×

Send article to Dropbox

To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

The usefulness of brain natriuretic peptide in simple congenital heart disease – a systematic review
Available formats
×

Send article to Google Drive

To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

The usefulness of brain natriuretic peptide in simple congenital heart disease – a systematic review
Available formats
×
×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *